Worsening of callus hyperplasia after bisphosphonate treatment in type V osteogenesis imperfecta

被引:0
作者
Prajnya Ranganath
Joshi Stephen
Raju Iyengar
Shubha R. Phadke
机构
[1] Nizam’s Institute of Medical Sciences,Department of Medical Genetics
[2] Nizam’s Institute of Medical Sciences,Department of Orthopaedics
[3] SGPGIMS,Department of Medical Genetics
来源
Indian Pediatrics | 2016年 / 53卷
关键词
Bisphosphonates; Fractures; Osteogenesis imperfecta;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:250 / 252
页数:2
相关论文
共 43 条
[1]  
Van Dijk FS(2014)Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment Am J Med Genet A. 164A 1470-81
[2]  
Sillence DO(2014)What is new in genetics and osteogenesis imperfecta classification? J Pediatr 90 536-41
[3]  
Valadares ER(2000)Type V osteogenesis imperfecta: a new form of brittle bone disease J Bone Miner Res. 15 1650-8
[4]  
Carneiro TB(2013)A recurrent mutation in the 5’-UTR of IFITM5 causes osteogenesis imperfecta type V Am J Med Genet A. 161A 1980-2
[5]  
Santos PM(2007)Natural history of hyperplastic callus formation in osteogenesis imperfecta type V J Bone Miner Res. 22 1181-6
[6]  
Oliveira AC(2006)The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V Bone. 38 13-20
[7]  
Zabel B(2014)Bisphosphonate therapy for osteogenesis imperfecta Cochrane Database Syst Rev. 7 CD005088-53
[8]  
Glorieux FH(2012)Implications for fracture healing of current and new osteoporosis treatments: An ESCEO consensus paper Calcif Tissue Int. 90 343-8
[9]  
Rauch F(2012)A single recurrent mutation in the 52 -UTR of IFITM5 causes osteogenesis imperfecta type V Am J Hum Genet. 91 343-undefined
[10]  
Plotkin H(undefined)undefined undefined undefined undefined-undefined